Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE Study
Authors:
- Lara A. RayLRLara A. Ray
- David W. OslinDODavid W. Oslin
- 1 December 2009
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 105 (3) , 256-258
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype‐Based ApproachAlcohol, Clinical and Experimental Research, 2009
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol DependenceArchives of General Psychiatry, 2008
- Association of an Asn40Asp (A118G) polymorphism in the μ-opioid receptor gene with substance dependence: A meta-analysisDrug and Alcohol Dependence, 2006
- Opioid antagonists for alcohol dependence2005
- A Polymorphism of the μ‐Opioid Receptor Gene (OPRM1) and Sensitivity to the Effects of Alcohol in HumansAlcohol, Clinical and Experimental Research, 2004
- Will tomorrow's medicines work for everyone?Nature Genetics, 2004
- Testing Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (The COMBINE Study): A Pilot Feasibility StudyAlcohol, Clinical and Experimental Research, 2003
- Naltrexone for alcohol dependence: a randomized controlled trialAddiction, 2001
- Naltrexone and Cue Exposure With Coping and Communication Skills Training for Alcoholics: Treatment Process and 1‐Year OutcomesAlcohol, Clinical and Experimental Research, 2001
- A power primer.Psychological Bulletin, 1992